Growth Metrics

Trinity Biotech (TRIB) Retained Earnings (2016 - 2025)

Trinity Biotech's Retained Earnings history spans 17 years, with the latest figure at $4.3 million for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 18756.52% to $4.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 million, a 18756.52% increase, with the full-year FY2025 number at $4.3 million, up 18756.52% from a year prior.
  • Retained Earnings hit $4.3 million in Q4 2025 for Trinity Biotech, up from -$93.7 million in the prior quarter.
  • Over the last five years, Retained Earnings for TRIB hit a ceiling of $4.3 million in Q4 2025 and a floor of -$93.7 million in Q2 2025.
  • Historically, Retained Earnings has averaged -$24.7 million across 5 years, with a median of -$13.3 million in 2021.
  • Biggest five-year swings in Retained Earnings: tumbled 183295.65% in 2023 and later surged 18756.52% in 2025.
  • Tracing TRIB's Retained Earnings over 5 years: stood at $23000.0 in 2021, then tumbled by 116165.22% to -$26.7 million in 2022, then crashed by 82.22% to -$48.6 million in 2023, then surged by 100.05% to $23000.0 in 2024, then surged by 18756.52% to $4.3 million in 2025.
  • Business Quant data shows Retained Earnings for TRIB at $4.3 million in Q4 2025, -$93.7 million in Q2 2025, and $23000.0 in Q4 2024.